Log in to save to my catalogue

The Role of Insulin Receptor Isoforms and Hybrid Insulin/IGF-I Receptors in Human Cancer

The Role of Insulin Receptor Isoforms and Hybrid Insulin/IGF-I Receptors in Human Cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_70241479

The Role of Insulin Receptor Isoforms and Hybrid Insulin/IGF-I Receptors in Human Cancer

About this item

Full title

The Role of Insulin Receptor Isoforms and Hybrid Insulin/IGF-I Receptors in Human Cancer

Author / Creator

Publisher

United Arab Emirates: Bentham Science Publishers Ltd

Journal title

Current pharmaceutical design, 2007-03, Vol.13 (7), p.671-686

Language

English

Formats

Publication information

Publisher

United Arab Emirates: Bentham Science Publishers Ltd

More information

Scope and Contents

Contents

This review will focus on the emerging role of the insulin receptor (IR) in cancer. Several epidemiological studies have shown that insulin resistance states, characterized by hyperinsulinemia, are associated with an increased risk for a number of malignancies, including carcinomas of the breast, prostate, colon and kidney. Recent data have elucida...

Alternative Titles

Full title

The Role of Insulin Receptor Isoforms and Hybrid Insulin/IGF-I Receptors in Human Cancer

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_70241479

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_70241479

Other Identifiers

ISSN

1381-6128

E-ISSN

1873-4286

DOI

10.2174/138161207780249173

How to access this item